VMD

VMD is a Belgian company specializing in veterinary medical products and services, dedicated to enhancing animal health and welfare through innovative solutions. Founded in 1973 and headquartered in Belgium, VMD develops veterinary pharmaceuticals and related products. In September 2007, the company received EUR 3 million financing from KBC Private Equity. There are no known pivots in business strategy or affiliations with parent companies or subsidiaries.

VMD's core offerings focus on veterinary pharmaceuticals designed to address challenges in animal health. Their products enhance operational efficiency and improve animal care, serving a diverse client base from small to large enterprises. VMD markets its solutions primarily in North America, Western Europe, and parts of Asia, where they have established a strong reputation for reliability. In the most recent year of 2022, VMD reported a revenue amount of EUR 1,412,722,799.

80, with an EBITDA of EUR 508,668,727, reflecting a robust financial foundation built on a model that incorporates direct sales and subscription-based services. VMD plans to leverage the recent EUR 3 million funding to bolster its product development and expand into new geographical markets. There are upcoming product launches aimed at enhancing their veterinary offerings, with targeted expansions in markets across Asia and North America expected by 2025. The funding will primarily support these product innovations and market entry strategies.